Dr Reddy's inks pact worth USD150 million with Citius Pharma to sell all rights to anti-cancer agent E7777
Dr Reddy's Laboratories on Saturday said it has inked a pact with US-based Citius Pharmaceuticals to sell its rights to an anti-cancer agent.
The drug firm said it has entered into a definitive agreement with Citius to sell all of its rights to E7777 (an engineered IL-2-diphtheria toxin fusion protein) and certain related assets. Source: PTI